Global Chimeric Antigen Receptor Cell Therapy Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Monotherapy
  • 1.4.3 Combination Therapy
• 1.5 Market by Application
  • 1.5.1 Global Chimeric Antigen Receptor Cell Therapy Market Share by Application (2014-2025)
  • 1.5.2 Acute Leukemia
  • 1.5.3 Non-hodgkin's Lymphoma
  • 1.5.4 Multiple Myeloma
  • 1.5.5 Transplant Rejection
  • 1.5.6 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Chimeric Antigen Receptor Cell Therapy Market Size
• 2.2 Chimeric Antigen Receptor Cell Therapy Growth Trends by Regions
  • 2.2.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2014-2025)
  • 2.2.2 Chimeric Antigen Receptor Cell Therapy Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Chimeric Antigen Receptor Cell Therapy Market Size by by Players
  • 3.1.1 Global Chimeric Antigen Receptor Cell Therapy Revenue by by Players (2014-2019)
  • 3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Chimeric Antigen Receptor Cell Therapy Market Concentration Ratio (CR5 and HHI)
• 3.2 Chimeric Antigen Receptor Cell Therapy Key Players Head office and Area Served
• 3.3 Key Players Chimeric Antigen Receptor Cell Therapy Product/Solution/Service
• 3.4 Date of Enter into Chimeric Antigen Receptor Cell Therapy Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2014-2019)
• 4.2 Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2014-2019)

5 United States

• 5.1 United States Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
• 5.2 Chimeric Antigen Receptor Cell Therapy Key Players in United States
• 5.3 United States Chimeric Antigen Receptor Cell Therapy Market Size by Type
• 5.4 United States Chimeric Antigen Receptor Cell Therapy Market Size by Application

6 Europe

• 6.1 Europe Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
• 6.2 Chimeric Antigen Receptor Cell Therapy Key Players in Europe
• 6.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type
• 6.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application

7 China

• 7.1 China Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
• 7.2 Chimeric Antigen Receptor Cell Therapy Key Players in China
• 7.3 China Chimeric Antigen Receptor Cell Therapy Market Size by Type
• 7.4 China Chimeric Antigen Receptor Cell Therapy Market Size by Application

8 Japan

• 8.1 Japan Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
• 8.2 Chimeric Antigen Receptor Cell Therapy Key Players in Japan
• 8.3 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Type
• 8.4 Japan Chimeric Antigen Receptor Cell Therapy Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
• 9.2 Chimeric Antigen Receptor Cell Therapy Key Players in Southeast Asia
• 9.3 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Type
• 9.4 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size by Application

10 India

• 10.1 India Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
• 10.2 Chimeric Antigen Receptor Cell Therapy Key Players in India
• 10.3 India Chimeric Antigen Receptor Cell Therapy Market Size by Type
• 10.4 India Chimeric Antigen Receptor Cell Therapy Market Size by Application

11 Central & South America

• 11.1 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size (2014-2019)
• 11.2 Chimeric Antigen Receptor Cell Therapy Key Players in Central & South America
• 11.3 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Type
• 11.4 Central & South America Chimeric Antigen Receptor Cell Therapy Market Size by Application

12 International Players Profiles

• 12.1 Amgen Inc
  • 12.1.1 Amgen Inc Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.1.4 Amgen Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.1.5 Amgen Inc Recent Development
• 12.2 Autolus Therapeutics Plc
  • 12.2.1 Autolus Therapeutics Plc Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.2.4 Autolus Therapeutics Plc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.2.5 Autolus Therapeutics Plc Recent Development
• 12.3 Beijing Immunochina Medical Science & Technology Co Ltd
  • 12.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Recent Development
• 12.4 Bellicum Pharmaceuticals Inc
  • 12.4.1 Bellicum Pharmaceuticals Inc Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.4.4 Bellicum Pharmaceuticals Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.4.5 Bellicum Pharmaceuticals Inc Recent Development
• 12.5 Bristol-Myers Squibb Co
  • 12.5.1 Bristol-Myers Squibb Co Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.5.4 Bristol-Myers Squibb Co Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.5.5 Bristol-Myers Squibb Co Recent Development
• 12.6 bluebird bio Inc
  • 12.6.1 bluebird bio Inc Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.6.4 bluebird bio Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.6.5 bluebird bio Inc Recent Development
• 12.7 CARsgen Therapeutics Ltd
  • 12.7.1 CARsgen Therapeutics Ltd Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.7.4 CARsgen Therapeutics Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.7.5 CARsgen Therapeutics Ltd Recent Development
• 12.8 Celgene Corp
  • 12.8.1 Celgene Corp Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.8.4 Celgene Corp Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.8.5 Celgene Corp Recent Development
• 12.9 Cell Medica Ltd
  • 12.9.1 Cell Medica Ltd Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.9.4 Cell Medica Ltd Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.9.5 Cell Medica Ltd Recent Development
• 12.10 Cellular Biomedicine Group Inc
  • 12.10.1 Cellular Biomedicine Group Inc Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Chimeric Antigen Receptor Cell Therapy Introduction
  • 12.10.4 Cellular Biomedicine Group Inc Revenue in Chimeric Antigen Receptor Cell Therapy Business (2014-2019)
  • 12.10.5 Cellular Biomedicine Group Inc Recent Development
• 12.11 Celularity Inc
• 12.12 Celyad SA
• 12.13 Daiichi Sankyo Co Ltd
• 12.14 Fosun Pharmaceutical AG
• 12.15 Gilead Sciences Inc
• 12.16 Guangzhou Anjie Biomedical Technology Co Ltd
• 12.17 Hangzhou Converd Co Ltd
• 12.18 Hebei Senlang Biotechnology Inc Ltd
• 12.19 HRAIN Biotechnology Co Ltd
• 12.20 Juno Therapeutics Inc
• 12.21 Kite Pharma Inc
• 12.22 Nanjing Legend Biotech Co Ltd
• 12.23 NantKwest Inc
• 12.24 Nkarta Inc
• 12.25 Novartis AG
• 12.26 Ono Pharmaceutical Co Ltd
• 12.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
• 12.28 Sorrento Therapeutics Inc
• 12.29 Takara Bio Inc

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer